Bert F - Search Results

1

Cellular and humoral immune responses of cancer patients to defined tumor antigens.

Jäger D, Jäger E, Bert F, Knuth A. Jäger D, et al. Among authors: bert f. Cancer Chemother Biol Response Modif. 2001;19:385-93. Cancer Chemother Biol Response Modif. 2001. PMID: 11686025 Review. No abstract available.

2

Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum.

Jäger D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jäger E, Old LJ, Chen YT, Knuth A. Jäger D, et al. Among authors: bert f. Cancer Immun. 2002 Jun 28;2:5. Cancer Immun. 2002. PMID: 12747750

3

Dose escalation study for defining the maximum tolerated dose of continuous oral trofosfamide in pretreated patients with metastatic lung cancer.

Al-Batran SE, Atmaca A, Bert F, Jäger D, Frisch C, Neumann A, Orth J, Knuth A, Jäger E. Al-Batran SE, et al. Among authors: bert f. Onkologie. 2004 Dec;27(6):534-8. doi: 10.1159/000081334. Onkologie. 2004. PMID: 15591711 Clinical Trial.

4

Outcomes and Costs of Treating Hepatitis C Patients in the Era of First Generation Protease Inhibitors - Results from the PAN Study.

Stahmeyer JT, Rossol S, Bert F, Böker KH, Bruch HR, Eisenbach C, Link R, John C, Mauss S, Heyne R, Schott E, Pfeiffer-Vornkahl H, Hüppe D, Krauth C. Stahmeyer JT, et al. Among authors: bert f. PLoS One. 2016 Jul 28;11(7):e0159976. doi: 10.1371/journal.pone.0159976. eCollection 2016. PLoS One. 2016. PMID: 27467772 Free PMC article.

5

Cost of treating hepatitis C in Germany: a retrospective multicenter analysis.

Stahmeyer JT, Rossol S, Bert F, Antoni C, Demir M, Hinrichsen H, Hüppe D, Teuber G, Wiebner B, Wedemeyer H, Krauth C. Stahmeyer JT, et al. Among authors: bert f. Eur J Gastroenterol Hepatol. 2014 Nov;26(11):1278-85. doi: 10.1097/MEG.0000000000000181. Eur J Gastroenterol Hepatol. 2014. PMID: 25144493

6

Costs and outcomes of treating chronic hepatitis C patients in routine care - results from a nationwide multicenter trial.

Stahmeyer JT, Krauth C, Bert F, Pfeiffer-Vornkahl H, Alshuth U, Hüppe D, Mauss S, Rossol S. Stahmeyer JT, et al. Among authors: bert f. J Viral Hepat. 2016 Feb;23(2):105-15. doi: 10.1111/jvh.12471. Epub 2015 Sep 28. J Viral Hepat. 2016. PMID: 26411532

7

High prevalence of chronic hepatitis B and C virus infection in a population of a German metropolitan area: a prospective survey including 10 215 patients of an interdisciplinary emergency unit.

Bert F, Rindermann A, Abdelfattah MA, Stahmeyer JT, Rossol S. Bert F, et al. Eur J Gastroenterol Hepatol. 2016 Nov;28(11):1246-52. doi: 10.1097/MEG.0000000000000702. Eur J Gastroenterol Hepatol. 2016. PMID: 27439034

8

[Acute exacerbation of reactivated chronic hepatitis-b after stopping antiviral medication followed by loss of HBsAg].

Bert F, Rossol S. Bert F, et al. Dtsch Med Wochenschr. 2020 Apr;145(8):552-554. doi: 10.1055/a-1120-3930. Epub 2020 Apr 15. Dtsch Med Wochenschr. 2020. PMID: 32294781 German.

9

[Costs of a guideline-based treatment of patients with chronic hepatitis C in Germany].

Stahmeyer JT, Rossol S, Bert F, Abdelfattah M, Krauth C. Stahmeyer JT, et al. Among authors: bert f. Z Gastroenterol. 2014 Sep;52(9):1041-9. doi: 10.1055/s-0034-1366289. Epub 2014 Jul 30. Z Gastroenterol. 2014. PMID: 25075995 German.

10

[Costs of a guideline-based treatment of patients with chronic hepatitis C in the era of interferon-free treatment].

Stahmeyer JT, Rossol S, Bert F, Liersch S, Krauth C. Stahmeyer JT, et al. Among authors: bert f. Z Gastroenterol. 2016 Aug;54(8):760-9. doi: 10.1055/s-0042-105655. Epub 2016 Aug 16. Z Gastroenterol. 2016. PMID: 27529526 German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

312 results

Search Page

Filters